FUW-tetO-SOX9 Citations (2)

Originally described in: NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells.
Tchieu J, Calder EL, Guttikonda SR, Gutzwiller EM, Aromolaran KA, Steinbeck JA, Goldstein PA, Studer L Nat Biotechnol. 2019 Mar;37(3):267-275. doi: 10.1038/s41587-019-0035-0. Epub 2019 Feb 25. PubMed Journal

---

Articles Citing FUW-tetO-SOX9

Articles
Enhanced disc regeneration through CRISPR/Cas9-mediated SOX9 and TGFbeta1 coexpression in tonsil-derived mesenchymal stromal cells. Lee S, Yu Y, Kim DH, Bock M, Kim Y, An SB, Choi H, Shin HE, Hwang DY, Han I. Stem Cell Res Ther. 2025 Sep 25;16(1):501. doi: 10.1186/s13287-025-04600-2. PubMed
Druggable genome CRISPR screening identifies the KEAP1/NRF2 axis as a mediator of PD-L1 expression. Seker-Polat F, Rogozinska M, Ban Y, Abdula F, Buyukcelebi K, Xie P, Fan J, Abbaszadeh N, Kingham Y, Paylakhi SZ, Zhang B, Adli M. Commun Biol. 2025 Nov 19;8(1):1610. doi: 10.1038/s42003-025-08983-z. PubMed

If you have published an article using this material, please email us at to have your article added to this page.